Efficacy and Safety of a Once-Yearly i.v. Infusion of Zoledronic Acid 5mg Versus a Once-Weekly 70-mg Oral Alendronate in the Treatment of Male Osteoporosis: A Randomized, Multicenter, Double-Blind, Active-Controlled Study

Autor:	B.L. Clarke
Rok vydání:	2011
Předmět:	Double blind medicine.medical_specialty Zoledronic acid business.industry Osteoporosis I v infusion medicine Urology Once weekly medicine.disease business medicine.drug
Zdroj:	Yearbook of Endocrinology. 2011:195-197
ISSN:	0084-3741
DOI:	10.1016/j.yend.2011.04.008
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e6fe0862aa535d4d3ce36ecae6f25b5 https://doi.org/10.1016/j.yend.2011.04.008 Zobrazit plný text záznamu